Global Bio-chem Technology Group Company Limited
GBCMYOTCConsumer Defensive● Active
$0.41
+$0.00(+0.00%)
Market Cap$73875900
P/E Ratio—
52W High$0.4873
52W Low$0.3226
Global Bio-chem Technology Group Company Limited (GBCMY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GBCMY · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.27B | $2.00B | $1.37B | $0.01B | $0.75B |
| Cost of Revenue | $2.08B | $1.78B | $1.33B | $0.34B | $0.70B |
| Gross Profit | $0.20B | $0.22B | $0.04B | $0.01B | $0.05B |
| Gross Margin %(computed) | 8.62% | 10.93% | 3.18% | 62.06% | 6.48% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.00B | $0.01B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.25B | $0.30B | $0.33B | $0.37B |
| Total Operating Expenses | $0.27B | $0.36B | $0.37B | $0.28B | $0.43B |
| Operating Income | ($0.08B) | ($0.14B) | ($0.32B) | ($0.27B) | ($0.39B) |
| Operating Margin %(computed) | -3.45% | -6.98% | -23.16% | — | -51.95% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.31B | $0.32B | $0.75B | $0.69B | $0.79B |
| Income Before Tax | $0.16B | $0.75B | $3.70B | ($1.42B) | ($0.41B) |
| Income Tax Expense | $0.00B | ($0.02B) | ($0.04B) | ($0.05B) | $0.03B |
| Net Income | $0.16B | $0.77B | $4.22B | ($1.44B) | ($0.40B) |
| Net Margin %(computed) | 6.86% | 38.46% | 307.48% | — | -53.69% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.72 | $4.30 | $23.50 | $-8.00 | $-2.25 |
| Wtd Avg Shares | 0.22B | 0.18B | 0.18B | 0.18B | 0.18B |
| EBITDA | $0.04B | $0.02B | ($0.04B) | ($0.47B) | $0.79B |
| EBITDA Margin %(computed) | 1.54% | 0.84% | -3.17% | — | 105.24% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · HKD · B
Explore more Global Bio-chem Technology Group Company Limited data
About Global Bio-chem Technology Group Company Limited (GBCMY) Income Statement
Global Bio-chem Technology Group Company Limited (GBCMY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GBCMY reported revenue of $2.27B, gross profit of $0.20B (gross margin 8.62%), and net income of $0.16B — a net profit margin of 6.86%.
Frequently asked questions
GBCMY · 4 questionsGlobal Bio-chem Technology Group Company Limited (GBCMY) reported revenue of $2.27B for 2025, up 13.7% year-over-year.
GBCMY revenueGBCMY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09